Uterine fluid from unilaterally pregnant ewes contains activity inhibitory to lymphocyte proliferation. The molecules responsible for this activity may thereby regulate uterine immune responses during pregnancy. The purpose of the experiment described here was to identify the major protein in uterine fluid responsible for this activity. When uterine fluid was fractionated by a combination of cation exchange chromatography, gel filtration, and lectin affinity chromatography, the majority of the lymphocyte activity co-migrated with a pair of proteins previously identified as related, serpin-like glycoproteins. Together, this pair of proteins, called the uterine milk proteins (UTM-proteins), are the predominant endometrial secretory protein produced under the influence of progesterone. Preparations of uterine protein highly enriched for the UTM-proteins inhibited lymphocyte proliferation induced by phytohemagglutinin, concanavalin A, and mixed lymphocyte reactions but did not inhibit proliferation induced by pokeweed mitogen. In some experiments, UTM-proteins also reduced viability of cultured lymphocytes. Another previously described lymphocyte-inhibitory factor, megasuppressin, was also observed. Megasuppressin, which eluted at an apparent molecular weight of greater than 4 x 106 even after treatment with urea, guanidine-HCI, and P-mercaptoethanol, was a more potent inhibitor of lymphocyte proliferation than UTM-proteins. Megasuppressin is not very abundant, however, and probably is responsible for only a small fraction of the lymphocyte inhibitory activity in uterine fluid. The majority of lymphocyte-inhibitory activity is caused by the UTM-proteins or by a molecule that co-purifies in trace amounts with UTM-proteins.
INTRODUCTION
The mammalian uterus is exposed to infectious agents during mating and parturition. Not surprisingly, therefore, the uterine endometrium contains cellular elements of the immune system including lymphocytes, macrophages, and polymorphonuclear leukocytes [1] [2] [3] [4] [5] . Furthermore, intrauterine deposition of antigen can lead to humoral immunity [6, 7] , tissue-graft rejection [8, 9] , and rapid recruitment of polymorphonuclear leukocytes to the uterine endometrium and lumen [10, 11] . Because a competent immune system is in place, infections can be readily cleared from the uterus if the proper hormonal milieu is present [12] [13] [14] . One implication of the immunological competence of the uterus is that immune responses can be directed against spermatozoa and the conceptus [15, 16] . There is evidence that immune responses directed towards the conceptus could be either deleterious [17] or beneficial [18] to conceptus survival and development; furthermore, cytokines from lymphoid cells can enhance or reduce embryonic survival [19] .
As with other aspects of uterine function, lymphoid cells within the uterine endometrium are under hormonal control. One of the major regulatory hormones for these cells is progesterone, which has been shown to inhibit a variety of intrauterine immune-mediated responses [8, 9, [12] [13] [14] 20] .
In sheep, administration of progesterone delayed rejection of skin allografts placed within the uterine endometrium [9] and caused a reduction in the numbers of Major Histocompatability Complex (MHC) Class II + and CD45R + cells within the endometrium [5] . Actions of progesterone on uterine immune responses in sheep may be mediated in part by immunoregulatory substances produced by the endometrium. Treatment of ovariectomized ewes with progesterone results in an accumulation of uterine fluid that can inhibit blastogenic responses of cultured lymphocytes to mitogens and mixed lymphocyte reactions and reduce the development of T-cell-dependent antibody responses in vivo [21, 22] . These inhibitory factors are also present in uterine fluid of unilaterally pregnant ewes [23, 24] .
The identity of the immunoregulatory factors present in uterine fluid from progesterone-treated and pregnant ewes remains unclear. Two reports [25, 26] indicate that the serpin-like proteins present in uterine fluid can inhibit lymphocyte proliferation when given at high concentrations (> 400 pzg/ml). These proteins, usually termed the uterine milk proteins (UTM-proteins), are a pair of related glycoproteins of basic isoelectric point having molecular weights of 55 000 and 57 000 [27] . The UTM-proteins show sequence homology with members of the serpin superfamily of protease inhibitors [28] , are the most abundant proteins in uterine fluid of pregnant ewes [29, 30] , and can be induced by treatment with progesterone [29, 31, 32] . Related proteins are found in uterine fluid of cows [32] and pigs [33] .
Uterine fluid from progesterone-treated and unilaterally pregnant ewes also contains another glycoprotein possessing lymphocyte-inhibitory activity. In both of these fluids, lymphocyte-inhibitory activity can be identified in the frac-tion of basic proteins eluting at the void volume of a Sepharose CL-6B column (apparent Mr > 4 x 106) [21, 23, 24] . This fraction is rich in carbohydrate (35%), and lymphocyte-inhibitory activity can be reduced by treatment with protease or destruction of carbohydrate [24] . The factor responsible for this activity has been termed megasuppressin (MS) [34] . MS is a much more potent inhibitor of lymphocytes than UTM-proteins [21, 23, 24] but is not as abundant in uterine fluid as UTM-proteins. The purpose of the experiments described here was to determine whether UTMproteins, MS, or another protein was responsible for the majority of the lymphocyte-inhibitory activity found in uterine fluid. Another goal was to further characterize the biochemical properties of MS. Unilaterally pregnant ewes were used as a source of uterine fluid because these ewes have large amounts of uterine fluid that contains lymphocyte-inhibitory activity that has biochemical characteristics almost identical to inhibitory activity in uterine fluid from progesterone-treated ewes [21, 24] . Furthermore, the ligation is not believed to alter types of proteins produced by the endometrium because the electrophoretic pattern of proteins produced by the endometrium of the ligated uterine horn is very similar to that of the nonligated, pregnant uterine horn [30, 35] .
MATERIALS AND METHODS

Materials
Sigma (St. Louis, MO) was the source for RPMI-1640, Dulbecco's Modified Eagle's Medium, Dulbecco's PBS (DPBS), Histopaque 1077, phytohemagglutinin-L (PHA), concanavalin A (Con A), pokeweed mitogen (PWM), penicillin, streptomycin, glutamine, leupeptin, and pepstatin. For use in lymphocyte cultures, RPMI-1640 was modified to contain 10% iron-supplemented calf serum (HyClone, Logan, UT), 2% (v/v) extra 200 mM glutamine, 100 IU/ml penicillin, and 100 jxg/ml streptomycin. [ 3 H]Methyl thymidine (sp. act. 5.0 Ci/mmol) was purchased from Amersham (Arlington Heights, IL), and Na 125 I (carrier free) was from ICN Biochemicals (Irvine, CA). Bicinchonic acid and Iodobeads were obtained from Pierce (Rockford, IL). Sepharose CL-4B, Sepharose CL-6B, Sephacryl S-200 HR, carboxymethyl (CM)-Sepharose, Con A-Sepharose 4B, and disposable columns of Sephadex G25 (PD10 columns) were from Pharmacia (Piscataway, NJ). Affi-gel 10 was from BioRad (Richmond, CA).
The monoclonal antibody to UTM-proteins (clone HL 218) was described previously [36] . Porcine transforming growth factor f1 (TGF31) and rabbit affinity-purified antibody to porcine TGF31 that possesses neutralizing ability for TGF{31 and TGF32 (50% neutralization of TGFI1 at 3-5 ig/ml) was purchased from R&D Systems (Minneapolis, MN). Rabbit antiserum (T96) to a putative T-cell suppressor factor associated with murine pregnancy [37] was a gift of Dr. Ken Beaman, University of Health Sciences/Chicago Medical School, North Chicago, IL. Alkaline-phosphatase-conjugated antibodies (goat anti-rabbit IgG and goat anti-mouse IgG) were from Sigma.
Collection of Uterine Fluids
Uterine fluids were collected from the nonpregnant uterine horn of unilaterally pregnant ewes of Florida Native or Rambouillet breeding at 140 days of gestation by procedures described elsewhere [38] .
Lymphocyte Proliferation Assays
Lymphocytes were prepared from heparinized jugular blood of Rambouillet ewes by use of Ficoll-Histopaque [39] . 
Electrophoresis
One-dimensional SDS-PAGE was performed under reduced conditions with use of 12.5% (w/v) polyacrylamide gels. Protein samples were concentrated by acetone pre-cipitation; resuspended in 10 mM Tris-HCI (pH 6.8) containing 5% (w/v) SDS, 10% (w/v) sucrose, and 5% -mercaptoethanol; boiled; and then loaded unto a polyacrylamide gel consisting of a 4.5% polyacrylamide stacking gel (pH 6.8) and 12.5% running gel (pH 8.8). Proteins were stained with 0.125% Coomassie Blue R-250 dye.
Fractionation of Lymphocyte-Inhibitory Activity by Gel Filtration Chromatography
A pool of uterine fluid (50 ml) from 3-4 sheep was dialyzed (Mr cutoff 6000-8000) against three changes of 4 L 10 mM Tris-HCI (pH 8.2). Precipitated material was removed by centrifugation at 1700 x g for 20 min, and the supernatant was loaded unto a 12 x 2.5-cm column of CMSepharose that had been pre-equilibrated with 10 mM TrisHCl, pH 8.2 (column buffer). After the column was washed with several column volumes of column buffer, material bound to the column (basic fraction) was eluted with column buffer containing 0.5 M NaCI. Aliquots (70-80 ml) of basic fractions were further fractionated by gel filtration using a column of Sepharose CL-6B (108 x 5.5 cm) with 10 mM Tris-HCl (pH 8.2) containing 0.33 M NaCl as eluent. Eluted material was collected as 70 fractions of 26.5 ml each. Every five consecutive fractions were pooled, extensively dialyzed against deionized water, lyophilized, and reconstituted in one-tenth the original volume with DPBS containing 100 IU/ml penicillin and 100 ptg/ml streptomycin. Fractions were then evaluated for ability to inhibit proliferation of PHA-stimulated lymphocytes when added to cultures at a final concentration (v/v) of 5 and 20%. Protein composition of each fraction was also determined by SDS-PAGE. Analysis of the resolution of lymphocyte-inhibitory material by gel filtration chromatography using Sepharose CL-6B was performed three times with a total of two different preparations of pooled uterine fluid from 5 ewes.
Ammonium Sulfate Precipitation of Lymphocyte-Inhibitory Activity
For one preparation of uterine proteins, the pooled fraction from Sepharose CL-6B gel filtration having greatest lymphocyte-inhibitory activity (tubes 41-45; corresponding to elution volume of UTM-proteins) was further separated by sequential ammonium sulfate precipitation. To 4 ml of a 10-fold concentrated preparation of this fraction (concentrated via CX-10 immersible ultrafiltration devices; Millipore, Bedford, MA), successive 0.8-ml aliquots of saturated ammonium sulfate were added. After each addition of ammonium sulfate, the mixture was incubated 30 min at room temperature and then centrifuged 20 min at 15 000 x g. The precipitate was collected, and an additional 0.8 ml saturated ammonium sulfate was added to the supernatant. The procedure was repeated 12 times. In this manner, precipitates were collected at saturated ammonium sulfate concentrations that ranged from 17-71%. At the end of the procedure, the volume of the remaining supernatant was 12 ml. All precipitates were dissolved in 12 ml deionized water. Redissolved precipitates and the final supernatant were then extensively dialyzed against DPBS (4 changes, 4 L each), and antibiotics were added (final concentration of 100 IU/ ml penicillin and 100 g/ml streptomycin). Each fraction was tested for inhibition of PHA-induced lymphocyte proliferation and analyzed by SDS-PAGE.
Lymphocyte-Inhibitory Activity of Lectin-Purified UTMProteins
A pool of uterine fluid from two ewes was sequentially resolved by cation exchange chromatography using CMSepharose followed by ammonium sulfate precipitation as described earlier. The precipitate collected at 60% saturated ammonium sulfate was redissolved in 10 mM Tris-HCl (pH 8.2) containing 0.33 M NaCl, 0.7 jig/ml leupeptin, and 0.5 jig/ml pepstatin and further resolved by gel filtration using a 99.4 x 1.5-cm column of Sepharose S-200 HR with the aforementioned buffer as eluent. Fractions eluting at the elution volume characteristic of UTM-proteins were pooled, adjusted to pH 7.4 with HCI, and concentrated 3.5-7 fold with a Millipore CX-10 concentrator; and aliquots of -10-20 mg were loaded unto a 5-ml column of Con ASepharose 4B pre-equilibrated in column buffer (10 mM Tris-HCI, pH 7.4, containing 0.5 M NaC1, 0.7 jig/ml leupeptin, and 0.5 ig/ml pepstatin). The column was washed with column buffer, and proteins were eluted with sequential washes of 0.5 M ot-D-methyl-glucoside in column buffer, 0.1 M ot-D-methyl-mannoside in column buffer, and 0.5 M a-D-methyl-mannoside in 90:10 (v/v) column buffer:ethylene glycol. The UTM-proteins were eluted with the 0.5-M ot-Dmethyl-glucoside step and dialyzed against DPBS, and protein concentration was determined by the method of Lowry et al. [40] with BSA as a standard. Antibiotics were then added, and the proteins were tested for inhibition of PHA-stimulated lymphocyte proliferation when added at concentrations of 50, 100, and 200 jig/ml. The assay was performed twice with two lymphocyte donors.
Characterization of Effects of UTM-Proteins on Lymphocyte Proliferation
For these studies, UTM-proteins were purified from uterine fluid by a combination of cation exchange chromatography using CM-Sepharose and gel filtration using Sepharose CL-6B as described above. As a final step, the UTM-proteins were placed over a column consisting of monoclonal antibody to UTM-proteins (HL 218) coupled to Affi-gel 10. Proteins were loaded onto the column in 10 mM Tris-HCI (pH 8.2), a condition that allowed maximum binding of UTM-proteins due to immunoaffinity and cation-exchange effects. Bound proteins were eluted with 3 M NaSCN. Eluted UTM-proteins were dialyzed against water and lyophilized, and the mass of UTM-proteins was determined gravimetrically. The UTM-proteins were dissolved in DPBS containing antibiotics and then used in lymphocyte proliferation experiments.
In the first series of experiments, UTM-proteins were tested for inhibition of proliferation of lymphocytes stimulated with PHA, Con A, or PWM. The experiment was replicated 3-4 times using lymphocytes from a different donor for each replicate. Effects of UTM-proteins on MLR were also examined in three assays, using different combinations of donor lymphocytes for each assay. Finally, an experiment was carried out to determine the stage of PHA-induced lymphocyte proliferation that is inhibited by UTM-proteins. For this purpose, UTM-proteins were added to lymphocyte cultures at a final concentration of 0.5 and 1.0 mg/ml at 0, 6, 12, 24, and 48 h after the addition of PHA. Addition of [ 3 H]TdR was at 48 h, and cells were collected at 60 h. The experiment was performed once using triplicate determinations of [3H]TdR uptake and a single determination of viability at the end of culture.
Presence of TGF(3 and T-Cell Suppressor Factor in Uterine Fluid
An ELISA was performed to determine whether one preparation of UTM-proteins (purified by sequential cation exchange, gel filtration chromatography, and immunoaffinity chromatography) and a sample of uterine fluid (from a unilaterally pregnant ewe at Day 100 of gestation) contained proteins that cross-reacted with two known inhibitors of lymphocyte proliferation: TGF{3 [41, 42] and a putative T-cell suppressor factor implicated in conceptus survival in mice [37, 43] . The ELISA was performed as previously described [30] . Antigen (UTM-proteins or uterine fluid) was coated at a concentration of 10 ptg/ml; blocker was 1% (w/ v) gelatin; primary antibodies used were mouse monoclonal antibody to UTM-proteins, rabbit antibody to TGF3, or rabbit antiserum to T-cell suppressor factor; alkalinephosphatase-conjugated second antibodies were goat antimouse IgG (for anti-UTM-proteins) or goat anti-rabbit IgG (for other antibodies).
Another experiment was performed to determine whether antibody to TGFi could neutralize lymphocyte-inhibitory activity in preparations of UTM-proteins (prepared as described for studies with mitogens and MLR). PHA-stimulated lymphocytes were cultured with 1 mg/ml UTM-proteins, UTM-proteins + TGF3 neutralizing antibody (8 pLg/ well), antibody alone, or no treatment. The assay was replicated with lymphocytes from four different donor ewes. To verify that antibody could reverse effects of TGF3, lymphocytes from one ewe were cultured with 0, 1, 5, and 10 ng/ml porcine TGF[1 in the presence of 0, 4, or 8 Wpg of neutralizing antibody to TGF3. For both experiments, wells received [
3 H]TdR at 48 h and were harvested at 60 h.
Preparation of MS
MS was prepared from uterine fluid as described previously [24] . Briefly, the basic protein fraction of uterine fluid was obtained by cation exchange chromatography using CM-Sepharose. This fraction was further resolved by gel filtration using Sepharose CL-6B to obtain material eluting at Mr > 4 x 106 (i.e., at the void volume of Sepharose CL-6B).
Biochemical Characteristics of Radioiodinated Proteins in the MS Fraction
Iodination was carried out by incubation of 16-20 pLg MS with 500 pLCi 125I in the presence of a single Iodobead solid-phase radioiodination reagent in 1 ml of 1 M KPO 4 buffer (pH 7.4) for 5 min at room temperature. Subsequently, unreacted 1251I was separated from radioiodinated MS by chromatography on a Pharmacia PD-10 column preequilibrated with 10 mM KPO 4 buffer (pH 7.4) containing 0.9% (w/v) NaCI and 5% (w/v) gelatin. Radioiodinated MS was further purified by gel filtration using a 96 x 1.5 cm column of Sepharose CL-6B with 10 mM Tris-HCI (pH 8.2) containing 0.33 M NaCl as eluent.
To determine whether MS had a molecular weight greater than 4 x 106, 1-ml samples of iodinated MS (5-21 x 106 cpm) were fractionated by gel filtration using a column of Sepharose CL-4B (98.4 x 1.5 cm; void volume = 40 x 106) equilibrated in 10 mM Tris (pH 8.2) containing 0.33 M NaCI. To determine whether MS was composed of two or more subunits, samples of radioiodinated MS were also fractionated through a column of Sepharose CL-6B (95.7 x 1.5 cm) equilibrated with 6 M urea or 4 M guanidine hydrochloride in 10 mM Tris (pH 8.2) as eluent. One sample of radioiodinated MS was reduced and alkylated by incubating 1 ml 125 I-labeled MS in 4 M guanidine HCl containing 2.5% -mercaptoethanol for 4 h. Next, 60 mg solid iodoacetamide was added, and the sample was resolved by gel filtration using Sepharose CL-6B (95.7 x 1.5) with 4 M guanidineHCl in 10 mM Tris-HCI (pH 8.2) as eluent. For each chromatographic separation, 3-4-ml fractions were collected, and radioactivity was determined by means of a gamma counter.
Comparison of the Specific Inhibitory Activity of UTMproteins and MS
One preparation of MS and UTM-proteins (prepared by sequential purification by cation exchange chromatography and gel filtration using Sepharose CL-6B) were compared for relative potencies in inhibiting lymphocyte proliferation. Proteins were dialyzed against deionized water, and protein content was then determined by the method of Smith et al. [44] with BSA as a standard. The proteins were lyophilized, reconstituted in DPBS with antibiotics, and tested in triplicate for inhibition of PHA stimulation of lymphocytes at final concentrations of 0, 62.5, and 125 Fpg/ml (tested in two assays using lymphocytes from two donors), and 250 and 500 p.g/ml (tested in one assay). 
Statistical Analysis
Dose-dependent effects of UTM-proteins on [
3 H]TdR incorporation and viability of lymphocytes stimulated with PHA, Con A, PWM, and MLR were evaluated by least-squares analysis of variance with the General Linear Models program of the Statistical Analysis System [45] . Triplicate determinations carried out within an assay were averaged before analysis. Values for nonstimulated lymphocytes (cells without mitogen or, for MLR, cultures of cells from one donor only) were generally subtracted from values for stimulated cells before analysis. In some cases when incorporation of radioactivity into nonstimulated cells was very low (< 200 dpm), values were not subtracted from values for lectinstimulated lymphocytes. The mathematical model for analyzing data included effects of lymphocyte donor and concentration of UTM-proteins. Differences between concentrations were determined by Duncan's Multiple Range test.
RESULTS
Fractionation of Lymphocyte-Inhibitory Activity in Uterine Fluid
Three discernible peaks of protein were resolved when the basic protein fraction of uterine fluid was resolved by gel filtration chromatography using Sepharose CL-6B (Fig.  1) . The first was a small peak at the void volume of the column (Mr > 4 x 106), the second a large peak eluting at the elution volume of BSA (Mr = 66 000), and the third another large peak eluting just after chymotrypsinogen (Mr = 26 000). Every consecutive five fractions collected from each chromatography run using Sepharose CL-6B were pooled and tested for ability to inhibit proliferation of PHAstimulated lymphocytes. In each of three separations performed, there was a single peak of lymphocyte-inhibitory activity that eluted coincident with the second protein peak (Fig. 2) . In one run (Fig. 2) , there was no effect of these fractions on lymphocyte viability. In the other two cases, however, viability was reduced by the fractions containing peak activity. At a final concentration of 20%, lymphocyte proliferation was completely inhibited by the pooled fractions containing maximal inhibitory activity. Viability of cells treated with these inhibitory fractions ranged from 26-28% as compared to 50-60% for control lymphocytes. Analysis of each pooled fraction by SDS-PAGE demonstrated that lymphocyte-inhibitory activity co-eluted with the UTM-proteins (data not shown).
To further resolve lymphocyte-inhibitory activity, the most active pooled fraction from one Sepharose CL-6B separation was subjected to differential ammonium sulfate precipitation. Lymphocyte-inhibitory activity was precipitated at saturated ammonium sulfate concentrations of 50-58% (Fig.  3) . When analyzed by SDS-PAGE, precipitates at these concentrations were found to contain apparently purified UTMproteins; the only bands identified on the electrophoretograms were the 55 000-and 57 000-Mr UTM-proteins. As a final separation, UTM-proteins obtained by gel filtration and ammonium sulfate precipitation were further purified by affinity chromatography using Con A-Sepharose. The UTMproteins bound to the column and could be eluted with 0.5 M ot-D-methyl-glucoside. The UTM-proteins recovered in this fraction were very effective at inhibiting proliferation of PHA-stimulated lymphocytes. When tested on lymphocytes from two different ewes, UTM-proteins caused 54.8 ± 10.8%, 90.7 + 8.6%, and 100% 0.0% inhibition of [ 3 HjTdR uptake at concentrations of 50, 100, and 200 g/ml, respectively (means between-donor SEM). Viability at the end of culture averaged 66%, 55%, 39%, and 18% for 0, 50, 100, and 200 [Lg/ml UTM-proteins, respectively.
Inhibitory Properties of UTM-Proteins
Protein preparations highly enriched for UTM-proteins were evaluated for effects on different lymphocyte subpopulations. The UTM-protein preparations for these studies were prepared by sequential separation using CM-Sepharose, Sepharose CL-6B, and an anti-UTM-protein immunoaffinity column. It was subsequently shown that, under the buffer conditions used, the affinity column also possessed properties of a cation exchange column; therefore, the UTM-proteins prepared with this column should not be considered as immunoaffinity-purified.
The effects of UTM-protein preparations on proliferation of lectin-stimulated lymphocytes are shown in Figure 4 . UTMproteins caused a dose-dependent inhibition (p < 0.001) of lymphocytes stimulated with T-cell mitogens, PHA, and Con A, but had no effect on the T-and B-cell mitogen, PWM. UTM-proteins also caused inhibition of MLR (Fig. 5) . The lowest concentrations of UTM-proteins causing inhibition were 100, 300, and 500 pg/ml for PHA, Con A, and MLR, respectively. High concentrations of UTM-proteins (300 Izg/ ml and higher) also decreased viability of PHA-stimulated lymphocytes at the end of culture (p < 0.001). Similarly, viability for MLR was slightly but significantly (p < 0.001) reduced by UTM-proteins. There was no significant effect of UTM-proteins on viability of lymphocytes stimulated with Con A or PWM. Lymphocyte cultures were also performed with 1 mg/ml BSA and Ova as negative controls. Generally, neither protein reduced proliferation or viability, although BSA and Ova reduced (p < 0.001) proliferation of PWMstimulated cells slightly (Fig. 4) .
Another experiment was conducted to define which stages of PHA-induced mitogenesis are affected by UTM-proteins. This was determined by adding UTM-proteins to lymphocyte cultures at 0, 6, 12, 24, or 48 h after addition of PHA. UTM-proteins caused an inhibition of proliferation if added up to 24 h after addition of PHA (Fig. 6) . Addition of UTMproteins at 48 h did not have a clear effect on proliferation: uptake of [ 3 H]TdR by UTM-protein-treated lymphocytes was similar to values for lymphocytes receiving BSA or OVA. Inhibition of lymphocyte proliferation was accompanied by a loss in viability at the end of culture. For example, viability for cells where 1 mg/ml UTM-proteins was added at time 0 was 30% at the end of culture as compared to 66% for control cells.
Presence of TGFf and T-Cell Suppressor Factor
Analyses were performed to determine whether these two lymphocyte-inhibitory molecules were present in uterine fluid or preparations of UTM-proteins. Antibodies to TGF3 or the T-cell suppressor factor did not react in an ELISA with uterine fluid or UTM-proteins although an antibody to UTM-proteins reacted strongly with uterine fluid (results not shown). Addition of neutralizing antibody towards TGF3 to lymphocyte cultures did not reduce the inhibitory effect of UTM-proteins on lymphocyte proliferation. Addition of porcine TGF31 caused 0, 15, and 18% inhibition of [ 3 H]TdR incorporation at 1, 5, and 10 ng/ml, respectively. Effects of TGF31 were reduced if cells were also incubated with 4 g (7 and 0% inhibition at 5 and 10 ng/ml TGF31, respectively) or 8 pig antibody to TGF (4 and 11% inhibition caused by 5 and 10 ng/ml TGF{1, respectively).
Comparison of Lymphocyte-Inhibitory Activity of UTMProteins and MS
Data in Figure 7 represent the relative potencies of UTMproteins and MS in inhibiting lymphocyte proliferation. Whereas both molecules inhibited [ 3 H]TdR uptake by PHAstimulated lymphocytes, MS was more active than UTM-proteins on a concentration basis. For example, at a final concentration of 250 ,ug/ml, MS inhibited 60% of 3 H]TdR uptake by PHA-stimulated lymphocytes; the same concentration of UTM-proteins inhibited 20% of [ 3 H]TdR uptake. Neither MS nor UTM-proteins reduced cell viability at the end of culture.
Biochemical Properties of MS
Radioiodinated proteins in the fraction of uterine proteins containing MS were analyzed by several different methods to determine the size and subunit structure of MS. Radioiodinated MS eluted at the void volume of Sepharose CL-6B (void volume at Mr > 4 x 106) and Sepharose CL-4B columns (void volume at Mr > 40 x 106). The elution volume of radioiodinated MS using Sepharose CL-6B was not affected by treatment with 6 M urea or 4 M guanidineHCl, even when preceded by reduction and alkylation. The only peak identified after these treatments was a single peak of radioiodinated protein eluting at the void volume.
DISCUSSION
It has been well known that uterine fluid from unilaterally pregnant and progesterone-treated ewes contains proteinaceous factors that inhibit lymphocyte proliferation in vitro [9, 21, 23, 24] , but the identification of the specific proteins responsible for this activity has been controversial. Two earlier reports indicated that UTM-proteins can inhibit lymphocyte proliferation [25, 26] , but the conclusion that UTM-proteins are the major immunosuppressant in uterine fluid was called into question by findings that, when the basic protein fraction of uterine fluid was separated by Sepharose CL-6B, the fractions having the greatest activity on a mass-of-protein basis eluted at an apparent molecular weight of > 4 x 106 [21, 23, 24] . Nonetheless, results from the series of experiments described here provide compelling evidence that the majority of lymphocyte-inhibitory activity in uterine fluid of pregnant ewes, and presumably in uterine fluid of progesterone-treated ewes, is associated with UTM-proteins. Although the UTM-proteins are much less active on a concentration-of-protein basis than MS (Fig. 7) , there is a great deal more UTM-protein in uterine fluid than MS; consequentially, most of the lymphocyte-inhibitory activity co-eluted with UTM-proteins when fractions were assayed on an equal-volume basis rather than on an equalmass basis. Lymphocyte-inhibitory activity continued to coelute with UTM-proteins through purification steps involving ammonium sulfate chromatography or lectin affinity chromatography. The high concentrations of UTM-proteins required to cause inhibition of lymphocyte proliferation are physiological; concentrations of protein in uterine fluid of unilaterally pregnant ewes, most of which represent UTMproteins, average 11-30 mg/ml from Days 60-140 of pregnancy [35] . Purified UTM-proteins inhibited proliferation induced by two T-cell mitogens, PHA and con A, and also inhibited MLR, in which proliferation occurs primarily for CD4 + lymphocytes [46] . There was no effect of UTM-proteins on the Tand B-cell mitogen PWM. This result is in contrast to that found with crude uterine fluid, which inhibited proliferation induced by all three mitogens [21, 24] . Perhaps a factor distinct from UTM-proteins is responsible for inhibition of PWM-induced cells.
The mechanism of action by which UTM-proteins inhibit lymphocyte proliferation is unclear. The proteins differ from many other putative regulatory polypeptides of immune function in that high concentrations are required. It is possible that this reflects a trace contamination of UTM-protein preparations with more active molecules that are not detectable by electrophoresis. There was no evidence that UTMproteins or crude uterine fluid contained two such molecules-TGFO, implicated in decidual immunosuppression in mice [42] , and a T-cell suppressor factor implicated in the maintenance of pregnancy in mice [37, 43] . It is possible, however, that the antibodies used do not recognize homologues of these molecules in sheep uterine fluid or that the proteins were in other fractions of uterine fluid. It is unlikely that effects of UTM-proteins on lectin-induced proliferation reflect simple competition between lymphocytes and the oligosaccharide chains present on UTM-proteins for lectin because UTM-proteins inhibited MLR also. Moreover, UTM-proteins inhibited proliferation of PI-Astimulated lymphocytes when addition of UTM-proteins was delayed until 24 h after addition of PHA. By this time, binding of PHA to lymphocytes should have been maximal. As for earlier studies with crude uterine fluid [21, 24] and purified UTM-proteins [25] , the proteins did not inhibit proliferation if addition was delayed until 48 h after PHA stimulation. Thus, UTM-proteins act by blocking early stages of lymphocyte mitogenesis and probably do not simply interfere with transport of [ 3 H]TdR into lymphocytes. In some experiments, high concentrations of UTM-proteins decreased lymphocyte viability. Some of the effects of UTM-proteins on lymphocyte proliferation could therefore reflect effects on lymphocyte survival. This is not the only effect of UTM-proteins, however, since lymphocyte proliferation was also inhibited when there was no detrimental effect on viability. For example, in one study, 100 pLg/ml UTM-proteins inhibited proliferation of PHA-stimulated lymphocytes without affecting their viability (Fig. 4) , and viability was unaffected in other experiments with PHA (Figs. 2 and 7) and Con A (Fig. 4) . Generally, cytotoxicity was seen when inhibitory activity of UTM-proteins was greatest. In earlier studies, neither crude uterine fluid [21, 24] nor UTM-proteins [25] affected viability of mitogen-stimulated lymphocytes.
One possibility is that the ability of UTM-proteins to regulate lymphocyte proliferation is related to the serpin-like properties of the proteins. Ing and Roberts [28] have shown that the UTM-proteins show significant nucleotide sequence homology with this family of serine protease inhibitors. While UTM-proteins have not been shown to exhibit protease inhibitory activity [28] , the proteins do share with otl-antitrypsin the ability to bind IgA [47, 48] . Additionally, al-antitrypsin can inhibit proliferation of lymphocytes at high concentrations similar to those at which UTM-proteins are effective [49, 50] . Moreover, as for UTMproteins, a-i antitrypsin inhibited PHA and Con A-stimulated cells while not affecting cells stimulated with PWM [50] . It may be that UTM-proteins inhibit proteases involved in lymphocyte proliferation such as dipeptidyl aminopeptidase IV [51, 52] .
The results presented here confirm earlier observations that uterine fluid of the pregnant ewe contains a high molecular-weight protein capable of inhibiting lymphocyte proliferation. Proteins similar to MS have also been described in uterine fluid of pregnant cows [53] . It is apparent, however, that MS is not responsible for the majority of lymphocyte-inhibitory activity in uterine fluid. The molecular size of MS is unclear: experiments on the behavior of radiolabeled proteins in the MS fraction failed to provide an estimate of the molecular weight of MS since material continued to elute at the void volume of the column even when Sepharose CL-4B (exclusion limit 40 x 106) was used or after chemical treatments were performed to dissociate MS into subunits. Because MS is so large in size and also highly glycosylated [24] , it is likely that MS is a mucin or proteoglycan. Caution must be used in interpreting results of these experiments, however, because it is possible that the radiolabeled preparations used to determine chromatographic behavior of MS may contain other molecules in addition to MS.
In conclusion, these results indicate that the major lymphocyte-inhibitory activity in uterine fluid from unilaterally pregnant ewes is associated with the UTM-proteins. This implies that UTM-proteins may be responsible for mediating the inhibitory effects of progesterone on uterine immune function. This hypothesis can be tested in future experiments by evaluating whether UTM-proteins can mimic effects of progesterone on changes in endometrial subpopulations of lymphocytes [5] and intrauterine skin-graft rejection 9].
